Revenio Group Oyj (LON: 0KFH)

Market Cap	664.41M
Revenue (ttm)	85.28M
Net Income (ttm)	15.90M
Shares Out	n/a
EPS (ttm)	0.60
PE Ratio	41.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Apr 5, 2024

Volume	200
Average Volume	705
Open	29.66
Previous Close	29.72
Day's Range	29.66 - 29.66
52-Week Range	17.59 - 41.32
Beta	1.38
RSI	70.07
Earnings Date	Feb 13, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, ...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2001
• Employees: 207
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KFH

Financial Performance

In 2023, Revenio Group Oyj's revenue was 96.79 million, a decrease of -0.46% compared to the previous year's 97.23 million. Earnings were 19.11 million, a decrease of -12.15%.

Financial numbers in EUR